Category: Company News
-

Advantage Solutions Reports Second-Quarter Revenue Growth While Profitability Remains Under Pressure
The consumer-packaged goods services provider posted a second consecutive quarter of revenue growth but saw earnings decline as weakness in Branded Services and execution challenges in Retailer Services offset strong momentum in Experiential Services. Key Investor Takeaways Why ADV Stock Is in Focus Advantage Solutions (NASDAQ:ADV) reported second-quarter 2026 revenue of $889.5 million, up 1.8%…
-

Vivos Therapeutics Secures New U.S. Patent Expanding Protection for Vivos CARE Technology
The newly issued patent broadens intellectual property protection for Vivos’ flagship oral medical device platform, reinforcing its competitive position in the obstructive sleep apnea treatment market. Key Investor Takeaways Why VVOS Stock Is in Focus Vivos Therapeutics (NASDAQ:VVOS) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 12,697,190, covering aspects of…
-

Kaltura Reports Second-Quarter Revenue Growth as AI Deal Momentum Accelerates
The enterprise software company exceeded second-quarter guidance, reported record AI-related customer wins, and highlighted growing commercial traction for its agentic digital experience platform while maintaining its full-year outlook. Key Investor Takeaways Why KLTR Stock Is in Focus Kaltura (NASDAQ:KLTR) reported second-quarter 2026 revenue of $46.9 million, up 5% from the prior year, while subscription revenue…
-

Orion Energy Systems Reports 32% Revenue Growth as Return to Profit Supports Fiscal 2027 Outlook
Strong first-quarter revenue growth, expanding margins, and a return to profitability were supported by higher LED lighting demand and continued momentum across the company’s diversified energy solutions business. Key Investor Takeaways Why OESX Stock Is in Focus Orion Energy Systems (NASDAQ:OESX) reported fiscal first-quarter 2027 revenue of $25.7 million, up 32% from $19.6 million in…
-

Insulet Reports Second-Quarter Revenue Growth as Full-Year U.S. Omnipod Outlook Is Lowered
The diabetes device maker exceeded second-quarter revenue guidance but reduced its full-year U.S. Omnipod sales growth forecast as it continues scaling in the type 2 diabetes market. Key Investor Takeaways Why PODD Stock Is in Focus Insulet (NASDAQ:PODD) reported second-quarter 2026 revenue of $801.7 million, up 23.5% from a year earlier and above the high…
-

Strong cash flow + blue-chip customers = long-term growth
For many energy-service companies, a temporary slowdown in order timing can obscure the quality of the underlying business. OMS Energy Technologies (NASDAQ:OMSE) appears to be one such case.
-

Luckin Coffee Reports 28.5% Revenue Growth as Store Network Tops 36,000
Luckin Coffee (USOTC:LKNCY) reported strong second-quarter 2026 revenue growth and continued rapid store expansion, although same-store sales turned negative as the company lapped a strong prior-year comparison period and operating margins narrowed modestly. Key Investor Takeaways Why LKNCY Stock Is in Focus Luckin Coffee delivered another quarter of strong top-line growth, with total net revenue…
-

BioAdaptives Opens Commercial Orders for XcellaraHeart Following Convertible Debt Retirement
BioAdaptives (USOTC:BDPT) announced that it will open commercial ordering later this week for its XcellaraHeart™ cellular wellness formula, following the retirement of its largest outstanding convertible debt as the company expands its direct-to-consumer e-commerce strategy. Key Investor Takeaways Why BDTP Stock Is in Focus BioAdaptives announced that customers and distributors will be able to begin…
-

American Fusion Appoints Strategic Advisor Ahead of Texatron Fusion Engine Testing Program
American Fusion (USOTC:AMFN) has appointed nuclear physicist Dr. Noah D’Amico as Strategic Advisor, adding scientific and engineering expertise as the company prepares to begin the next phase of testing for its Texatron™ Fusion Engine™ at Texas Tech University. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion announced that Dr. Noah D’Amico has…
-

Anavex Announces Board Refresh as It Seeks to Strengthen Governance and Advance Drug Pipeline
Anavex Life Sciences (NASDAQ:AVXL) has nominated two new independent directors as part of a broader board refresh ahead of its 2026 Annual Meeting, while outlining its strategy to stabilize leadership, defend against a proxy challenge, and advance its lead drug candidate toward potential commercialization. Key Investor Takeaways Why AVXL Stock Is in Focus Anavex announced…